Mounjaro
- Active ingredient
- tirzepatide
- Class
- GIP and GLP-1 receptor agonist (dual agonist)
- Route
- Once-weekly subcutaneous injection
- Maker
- Eli Lilly
Educational only. This is educational, not medical advice. Everyone's body responds differently. Talk to your clinician before starting, stopping, changing, or tapering any medication, and work with your physician and a registered dietitian to personalize your approach.
Overview
Mounjaro is the type 2 diabetes brand of tirzepatide, a dual GIP/GLP-1 receptor agonist. It lowers blood sugar and, like its weight-management twin Zepbound, strongly reduces appetite.
People prescribed Mounjaro for diabetes often see significant weight loss as well, which is why the molecule was also developed and approved as Zepbound for obesity.
Vocabulary that comes up throughout this page: Tirzepatide, GIP receptor, GLP-1 receptor agonist and Off-label use.
Approval and use
| Approved for | Type 2 diabetes |
| Weight use | Weight loss with Mounjaro is off-label; the same molecule is approved for weight management under the brand Zepbound. |
Typical titration (informational)
Mounjaro uses the same low-start, step-up pattern as Zepbound, beginning around 2.5 mg weekly and increasing over months.
The maintenance dose is set by the prescriber for glucose control and tolerance.
Informational only.
Expected timeline
Glucose and appetite effects begin early; weight loss accumulates over months. Magnitude is similar to tirzepatide in obesity trials at comparable doses.
Common side effects
- Nausea and reduced appetite
- Diarrhea, constipation, vomiting
- Hypoglycemia risk when combined with certain diabetes drugs
- Fatigue early on
What happens when you stop Mounjaro
Stopping tirzepatide returns appetite signaling toward baseline while metabolic adaptation persists, so weight tends to climb back without a maintenance system, just like the other GLP-1-class drugs.
For people with diabetes, glucose control may also shift, which is another reason any change is a clinician decision.
Going deeper on the off-ramp: Mounjaro Withdrawal: What to Expect Week by Week After Stopping, Tapering Off Ozempic: What to Discuss With Your Doctor and Stopping GLP-1s: Ozempic, Wegovy, Zepbound, Mounjaro, Saxenda, and Rybelsus Compared.
The maintenance plan for after Mounjaro →Cost
Cash price is in the same range as other branded GLP-1s; diabetes coverage is often broader than weight-management coverage. Verify current pricing.
Typical cash price without coverage: about $1,080 per 28-day fill (checked Oct 2026).
Calculate your Mounjaro cost by dose and by how you pay.
How long Mounjaro stays in your system
Mounjaro has a half-life of about 5 days, so about half is gone after 5 days and about 97% after 25 days (five half-lives). Enter your last dose in the Mounjaro clearance timeline to see today's level and when appetite tends to return.
Frequently asked questions
Can Mounjaro be used for weight loss?
Mounjaro is approved for type 2 diabetes; weight loss is off-label. The same molecule (tirzepatide) is approved for weight management as Zepbound.
Stopping by drug
Ozempic (semaglutide)
Wegovy (semaglutide)
Zepbound (tirzepatide)
Mounjaro (tirzepatide)
Saxenda (liraglutide)
Rybelsus (oral semaglutide)
Sources & further reading
Every claim on this page is drawn from peer-reviewed research, clinical trials, or recognized health authorities. Read the source before making any decision about your health.